Thyroid hormone resistance without mutations in thyroid hormone receptor beta

Medical Science Monitor

Volumn 13, Issue 6, 2007, Pages

  Bottcher, Yvonne ^a   Paufler, Thomas ^b   Stehr, Thomas ^b   Bertschat, Frank Ludwig ^b   Paschke, Ralf ^a   Koch, Christian A ^a,c  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b Oncology and Nephrology   (Germany)

^c UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Hot spot regions; Mosaicism; Pituitary adenoma; Thyroid hormone receptor; Thyroid hormone resistance; TSH

Indexed keywords

ALLOPURINOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; THYROID HORMONE; THYROID HORMONE RECEPTOR BETA;

AGED; ARTICLE; ATTENTION DEFICIT DISORDER; CASE REPORT; ELECTROCARDIOGRAM; FAMILY HISTORY; GOUT; HERNIOPLASTY; HUMAN; HYPERTENSION; HYPERTHYROIDISM; HYPOTHYROIDISM; MALE; MOSAICISM; MUTATION; PHYSICAL DISEASE BY BODY FUNCTION; THYROID HORMONE RESISTANCE; THYROTROPIN BLOOD LEVEL; THYROTROPIN SECRETING ADENOMA;

EID: 34249822232     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/msm.484143     Document Type: Article

References (39)

1. Refetoff S, Weiss RE, Usala SJ: The syndromes of resistance to thyroid hormone. Endocr Rev, 1993; 14: 348-99
2. Beck-Peccoz P, Mannavola D, Persani L: Syndromes of thyroid hormone resistance. Ann Endocrinol, 2005; 66(3): 264-69
3. Kaplan MM, Swartz SL, Larsen PR: Partial peripheral resistance to thyroid hormone. Am J Med, 1981; 70(5): 1115-21
4. Beck-Peccoz P, Persani L: TSH-induced hyperthyroidism caused by a pituitary tumor. Nat Clin Pract Endocrinol Metab, 2006; 2(9): 524-28
5. Beck-Peccoz P, Brucker-Davis F, Persani L et al: Thyrotropin-secreting pituitary tumors. Endocr Rev, 1996; 17(6): 610-38
6. Ezzat S, Asa SL, Couldwell WT et al: The prevalence of pituitary adenomas: a systematic review. Cancer, 2004; 101(3): 613-19
7. Mohammed IA, Aldasouqi S, Schnute R et al: The syndrome of resistance to thyroid hormone, misdiagnosed and treated as thyrotoxicosis. Endocr Pract, 1998; 4(6): 391-95
8. Brucker-Davis F, Skarulis MC, Grace MB et al: Genetic and clinical features of 42 kindreds with resistance to thyroid hormone. the national institutes of health prospective study. Ann Intern Med, 1995; 123: 572-83
9. Parikh S, Ando S, Schneider A et al: Resistance to thyroid hormone in a patient without thyroid hormone receptor mutations. Thyroid, 2002; 12: 81-86
10. Weiss RE, Refetoff S: Resistance to thyroid hormone. Rev Endocr Metab Disord, 2000; 1: 97-108
11. Yen PM: Thyrotropin receptor mutations in thyroid diseases. Rev Endocr Metab Disord, 2000; 1: 123-29
12. Brucker-Davis F, Oldfield EH, Skarulis MC et al: Thyrotropin-secreting pituitary tumors: diagnostic criteria, thyroid hormone sensitivity, and treatment outcome in 25 patients followed at the National Institutes of Health. J Clin Endocrinol Metab, 1999; 84(2): 476-86
13. Fuhrer D, Koch CA, Trantakis C et al: TSHoma with low alpha subunit in a patient with longstanding asymptomatic hyperthyroidism. Thyroid, 2005; 15(5): 489-90
14. Koch CA, Skarulis MC, Patronas NJ, Sarlis NJ: TSH secreting pituitary adenoma: 16 years follow-up. Med Klin, 2000; 95(1): 49-50
15. Sarlis NJ, Gourgiotis L, Koch CA et al: MR imaging features of thyrotropin-secreting pituitary adenomas at initial presentation. AJR Am J Roentgenol, 2003; 181(2): 577-82
16. Beck-Peccoz P, Chatterjee VK: The variable clinical phenotype in thyroid hormone resistance syndrome. Thyroid, 1994; 4: 225-32
17. Weiss RE, Weinberg M, Refetoff S: Identical mutations in unrelated families with generalized resistance to thyroid hormone occur in cytosine-guanine-rich areas of the thyroid hormone receptor beta gene. Analysis of 15 families. J Clin Invest, 1993; 91: 2408-15
18. Adams M, Matthews C, Collingwood TN et al: Genetic analysis of 29 kindreds with generalized and pituitary resistance to thyroid hormone. Identification of thirteen novel mutations in the thyroid hormone receptor beta gene. J Clin Invest, 1994; 94: 506-15
19. Taniyama M, Ban Y, Momotani N et al: Three Japanese patients from two families with generalized resistance to thyroid hormone with mutations in exon 9 of the thyroid hormone receptor beta gene. Intern Med, 2001; 40: 756-58
20. Mamanasiri S, Yesil S, Dumitrescu AM et al: Mosaicism of a thyroid hormone receptor-beta gene mutation in resistance to thyroid hormone. J Clin Endocrinol Metab, 2006; 91(9): 3471-77
21. Parrilla R, Mixson AJ, McPherson JA et al: Characterization of seven novel mutations of the c-erba beta gene in unrelated kindreds with generalized thyroid hormone resistance. Evidence for two "hot spot" regions of the ligand binding domain. J Clin Invest, 1991; 88: 2123-30
22. Sakurai A, Nakai A, DeGroot LJ: Expression of three forms of thyroid hormone receptor in human tissues. Mol Endocrinol, 1989; 3: 392-99
23. Sakurai A, Takeda K, Ain K et al: Generalized resistance to thyroid hormone associated with a mutation in the ligand-binding domain of the human thyroid hormone receptor beta. Proc Natl Acad Sci USA, 1989; 86: 8977-81
24. Sadow P, Reutratkul S, Weiss RE, Refetoff S: Resistance to thyroid hormone in the absence of mutations in the thyroid hormone receptor genes. Curr Opin Endocrinol Diabetes, 2000; 7: 253-59
25. Florkowski CM, Brownlie BEW, Croxson MS et al: Thyroid hormone resistance: the role of mutational analysis. Intern Med J, 2006; 36: 738-41
26. Chistiakov DA, Savostanov KV, Turakulov RI et al: Further studies of genetic susceptibility to Graves's disease in a Russian population. Med Sci Monit, 2002; 8(3): CR180-84
27. Koch CA, Sarlis NJ: The spectrum of thyroid diseases in childhood and its evolution during transition to adulthood: natural history, diagnosis, differential diagnosis, and management. J Endocrinol Invest, 2001; 4(9): 659-75
28. Usala SJ: Molecular diagnosis and characterization of thyroid hormone resistance syndromes. Thyroid, 1991; 1: 361-67
29. McDermott JH, Agha A, McMahon M et al: A case of resistance to thyroid hormone without mutation in the thyroid hormone receptor beta. Ir J Med Sci, 2005; 174(4): 60-64
30. Wu SY, Sadow PM, Refetoff S, Weiss RE: Tissue responses to thyroid hormone in a kindred with resistance to thyroid hormone harboring a commonly occurring mutation in the thyroid hormone receptor beta gene (P453T). J Lab Clin Med, 2005; 146(2): 85-94
31. Despres N, Grant AM: Antibody interference in thyroid assays: a potential for clinical misinformation. Clin Chem, 1998; 44: 440-54
32. George PM, Sheat JM, Palmer BN: Detection of protein binding abnormalities in euthyroid hyperthyroxinemia. Clin Chem, 1988; 34: 1745-48
33. Hall WA, Luciano MG, Doppman JL et al: Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population. Ann Intern Med, 1994; 120: 817-20
34. Pohlenz J, Weiss RE, Macchia PE et al: Five new families with resistance to thyroid hormone not caused by mutations in the thyroid hormone receptor beta gene. J Clin Endocrinol Metab, 1999; 84: 3919-28
35. Reutrakul S, Sadow PM, Pannain S et al: Search for abnormalities of nuclear corepressors, coactivators, and a coregulator in families with resistance to thyroid hormone without mutations in thyroid hormone receptor beta or alpha genes. J Clin Endocrinol Metab, 2000; 85: 3609-17
36. Weiss RE, Hayashi Y, Nagaya T et al: Dominant inheritance of resistance to thyroid hormone not linked to defects in the thyroid hormone receptor alpha or beta genes may be due to a defective cofactor. J Clin Endocrinol Metab, 1996; 81: 4196-203
37. Huang SC, Koch CA, Vortmeyer AO et al: Duplication of the mutant RET allele in trisomy 10 or loss of the wild-type allele in MEN 2-associated pheochromocytoma. Cancer Res, 2000; 60: 6223-26
38. Koch CA, Huang SC, Moley JF et al: Allelic imbalance of the mutant and wild-type RET allele in MEN 2-associated medullary thyroid carcinoma. Oncogene, 2001; 20(53): 7808-11
39. Koch CA: Molecular pathogenesis of MEN2-associated tumors. Fam Cancer, 2005; 4: 3-7